Scientist II, Computational Biology, Pharma R&D
Tempus AI
Summary
We are seeking a Scientist II to join our Computational Biology, Pharma R&D team. We work at the intersection of biological data science and AI to support collaborations with major pharmaceutical partners. The role focuses on integrating large-scale molecular and clinical datasets, generating actionable insights for drug discovery and development, and building next-generation research tools that enhance the impact and efficiency of our work.
Job description
The successful candidate will combine strong computational and statistical skills with a deep interest in biology and translational science. They will be comfortable working with real-world data, engaging with external scientific stakeholders, and leveraging AI (foundation models, Large Language Models, agentic systems, etc.) to scale tasks and augment insights.
Key Responsibilities
- Pharma Collaboration & Strategy: Partner with pharmaceutical collaborators to execute computational research plans that leverage the Tempus multimodal platform to address key questions in target discovery, biomarker development, and clinical development.
- Computational Analysis & Insight Generation: Perform robust, reproducible analyses integrating genomic, transcriptomic, imaging, and clinical data. Apply appropriate statistical and computational methods to derive insights related to clinical trial design, patient selection, treatment response, resistance mechanisms, and disease biology.
- AI & LLM Innovation: Incorporate LLMs, agentic workflows, foundation models and other AI tools into day-to-day workflows to accelerate code development, discovery, documentation, review, and insight generation.
- Method Development and Platform Contribution: Evaluate, adapt, and implement new methods for the analysis of real-world, clinical, and omics datasets (e.g., survival analysis, causal inference, multimodal integration). Contribute to reusable code, internal packages, and best practices that can be applied across multiple collaborations and programs.
- Cross-Functional Collaboration: Work closely with colleagues in Research, Clinical, Data Science, and Engineering to refine analyses and build scalable solutions.
- Scientific Communication: Communicate complex methods and results clearly to both technical and non-technical stakeholders. Prepare and present internal reports, external-facing deliverables, and, where appropriate, manuscripts or conference materials that demonstrate the impact of Tempus data and technologies on partner programs.
Qualifications
- Education: PhD in Computational Biology, Bioinformatics, Biostatistics, Machine Learning, or a related field (or master’s degree with 3+ years of relevant experience).
- Technical Proficiency: Proficiency in R and/or Python, including experience with common computational biology and scientific computing libraries.
- Proficiency in using machine learning, LLM-based coding assistants (e.g., Claude Code, Codex), and agentic frameworks for biological/clinical research.
- Adherence to good software engineering practices (version control, modular code, documentation).
- Experience working with SQL and large relational databases.
- Strong grounding in statistics and data analysis, including study design considerations and interpretation of real-world clinical data.
- Scientific Knowledge: Strong understanding of cancer biology, immunology, or human disease mechanisms.
- Data Expertise: Demonstrated experience analyzing large-scale biological datasets (e.g., NGS, RNA-seq, other genomics or transcriptomics data), ideally in oncology, immunology, or human disease.
- Soft Skills: Excellent written and verbal communication skills with comfort in client-facing roles. Ability to thrive in a fast-paced, dynamic environment.
Preferred Skillsets
- Generative AI: Practical experience configuring or adapting LLMs, or using related tools/frameworks, to support scientific work.
- Specialized Modeling: Expertise in one or more of the following: Real-world evidence (RWE), survival analysis, causal inference, network/systems biology, or multimodal integration.
- Publication Record: A strong history of peer-reviewed publications or conference presentations.
- Drug Discovery Context: Understanding of the drug development lifecycle, from target discovery to clinical development.
Requirements
- PhD in Computational Biology, Bioinformatics, Biostatistics, Machine Learning, or a related field (or master’s degree with 3+ years of relevant experience).
- Proficiency in R and/or Python, including experience with common computational biology and scientific computing libraries.
- Proficiency in using machine learning, LLM-based coding assistants (e.g., Claude Code, Codex), and agentic frameworks for biological/clinical research.
- Adherence to good software engineering practices (version control, modular code, documentation).
- Experience working with SQL and large relational databases.
- Strong grounding in statistics and data analysis, including study design considerations and interpretation of real-world clinical data.
- Strong understanding of cancer biology, immunology, or human disease mechanisms.
- Demonstrated experience analyzing large-scale biological datasets (e.g., NGS, RNA-seq, other genomics or transcriptomics data), ideally in oncology, immunology, or human disease.
- Excellent written and verbal communication skills with comfort in client-facing roles.
- Ability to thrive in a fast-paced, dynamic environment.
Benefits
- Incentive compensation
- Restricted stock units
- Medical benefits
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.